CLDX compared with MBX: revenue, margins and what each company keeps, and the suppliers and customers both name

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

Compare

CLDXCelldex Therapeutics, Inc.

MBXMBX Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CLDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.8%▲+0.36%×0.04

May 8 '26±7.6%▲+1.95%×0.25

Q1 FY26±13.6%▼−0.58%×0.04

Q3 FY25±17.3%▲+7.50%×0.43

MBX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−0.55%—

May 7 '26±11.9%▲+8.06%×0.68

= impliedCLDX realized, solidMBX realized, hatchedOne scale, both sides: full bar = 18%× = |realized| ÷ impliedSource: market data

Q1 FY26

±16.9%

▼−3.42%

×0.20

Jan 12 '26±17.0%▲+15.19%×0.89

CLDXCelldex Therapeutics, Inc.

28.35· pre 27.87· delayed

Mkt cap$2.2BRevenue$22,000Q2 FY26Revenue$7MFY24

MBXMBX Biosciences, Inc.

48.43· pre 48.43· delayed

Pre-marketNov 5 '26delayed

Mkt cap$2.3BRevenue—Revenue—

Compare

Pre-marketNov 5 '26delayed

CLDXCelldex Therapeutics, Inc.

MBXMBX Biosciences, Inc.

28.35pre 27.87delayed

Price

48.43pre 48.43delayed

$2.2B

Mkt cap

$2.3B

Q2 FY26$22,000

Revenue

—

FY24$7M

Revenue

—

CLDX28.35vsMBX48.43Pre-marketNov 5 '26delayed